Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) (352214)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    This grant is focused on supporting research that provides a deeper mechanistic insight and establishes causal relationships between TDP-43 pathology and its phenotypic outcomes. It emphasizes the need for studies on the mechanistic interactions between TDP-43 and other co-pathologies like TMEM106B. Moreover, the grant encourages comparisons across various domains (mechanistic, molecular, structural, cellular, genetic, -omic, anatomical, neuropathological, etc.) among different TDP-43 proteinopathies, including but not limited to Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), and their overlaps with or without Alzheimer's disease neuropathologic change (AD-NC).

    Eligibility

    Organization's Location
    Lorem do, ut dolor, adipisicing magna, anim ad, duis aute, sit duis
    Program Location
    et dolore pariatur amet ea excepteur reprehenderit id laboris exercitation
    Organization Type

    Submission

    Visit Apply for more information.

    Similar grants